This study discovered that ITGB1 expression was adversely correlated with immune/stromal/ESTIMATE scores in SARC, indicating that ITGB1 was negatively correlated with immunological tolerance, potentially through tumor-associated macrophage contact with T cells. Here, ITGB1 is linked to neoplasm.